Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
2,353,800
-
Share change
-
+2,168,206
-
Total reported value
-
$70,135,600
-
Price per share
-
$29.81
-
Number of holders
-
14
-
Value change
-
+$64,614,511
-
Number of buys
-
8
-
Number of sells
-
4
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2025
As of 31 Dec 2025 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,353,800 shares of stock of the company.
Largest 10 holders included CONGRESS ASSET MANAGEMENT CO, Assenagon Asset Management S.A., NORDEA INVESTMENT MANAGEMENT AB, SG Americas Securities, LLC, Westview Management dba Westview Investment Advisors, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, CLARK FINANCIAL SERVICES GROUP INC /BD, NorthCrest Asset Manangement, LLC, Occidental Asset Management, LLC, and Trust Co of the South.
This table shows 14 institutional shareholders of the security as of 31 Dec 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.